Related references
Note: Only part of the references are listed.Enhanced myelopoiesis and aggravated arthritis in S100a8-deficient mice
Annabelle Cesaro et al.
PLOS ONE (2019)
Chronic sympathetic driven hypertension promotes atherosclerosis by enhancing hematopoiesis
Annas Al-Sharea et al.
HAEMATOLOGICA (2019)
Myeloid Slc2a1-Deficient Murine Model Revealed Macrophage Activation and Metabolic Phenotype Are Fueled by GLUT1
Alex J. Freemerman et al.
JOURNAL OF IMMUNOLOGY (2019)
SGLT2 inhibition reduces atherosclerosis by enhancing lipoprotein clearance in Ldlr-/- type 1 diabetic mice
Annas Al-Sharea et al.
ATHEROSCLEROSIS (2018)
Glucotypes reveal new patterns of glucose dysregulation
Heather Hall et al.
PLOS BIOLOGY (2018)
BloodSpot: a database of gene expression profiles and transcriptional programs for healthy and malignant haematopoiesis
Frederik Otzen Bagger et al.
NUCLEIC ACIDS RESEARCH (2016)
Adipose Tissue Macrophages Promote Myelopoiesis and Monocytosis in Obesity
Prabhakara R. Nagareddy et al.
CELL METABOLISM (2014)
miR33 Inhibition Overcomes Deleterious Effects of Diabetes Mellitus on Atherosclerosis Plaque Regression in Mice
Emilie Distel et al.
CIRCULATION RESEARCH (2014)
Role of bone-marrow- and non-bone-marrow-derived receptor for advanced glycation end-products (RAGE) in a mouse model of diabetes-associated atherosclerosis
Christine Koulis et al.
CLINICAL SCIENCE (2014)
Metabolic Reprogramming of Macrophages GLUCOSE TRANSPORTER 1 (GLUT1)-MEDIATED GLUCOSE METABOLISM DRIVES A PROINFLAMMATORY PHENOTYPE
Alex J. Freemerman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Hyperglycemia Promotes Myelopoiesis and Impairs the Resolution of Atherosclerosis
Prabhakara R. Nagareddy et al.
CELL METABOLISM (2013)
Eating patterns and type 2 diabetes risk in men: breakfast omission, eating frequency, and snacking
Rania A. Mekary et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2012)
Regulation of Hematopoietic Stem and Progenitor Cell Mobilization by Cholesterol Efflux Pathways
Marit Westerterp et al.
CELL STEM CELL (2012)
Extramedullary Hematopoiesis Generates Ly-6Chigh Monocytes That Infiltrate Atherosclerotic Lesions
Clinton S. Robbins et al.
CIRCULATION (2012)
Modulation of Glucose Transporter 1 (GLUT1) Expression Levels Alters Mouse Mammary Tumor Cell Growth In Vitro and In Vivo
Christian D. Young et al.
PLOS ONE (2011)
Hypoglycemia Assessed by Continuous Glucose Monitoring Is Associated with Preclinical Atherosclerosis in Individuals with Impaired Glucose Tolerance
Ersilia Castaldo et al.
PLOS ONE (2011)
Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials
Remy Boussageon et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
ATP-Binding Cassette Transporters and HDL Suppress Hematopoietic Stem Cell Proliferation
Laurent Yvan-Charvet et al.
SCIENCE (2010)
Vascular disease and diabetes: is hypoglycaemia an aggravating factor?
Rohana J. Wright et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2008)
Effects of intensive glucose lowering in type 2 diabetes
Hertzel C. Gerstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance - The Australian diabetes, obesity, and lifestyle study (AusDiab)
Elizabeth L. M. Barr et al.
CIRCULATION (2007)
Ly-6C(hi) monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata
Filip K. Swirski et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques
Frank Tacke et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Increased plasma S100A12 (EN-RAGE) levels in patients with type 2 diabetes
A Kosaki et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes - 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications study
TJ Orchard et al.
DIABETES CARE (2003)
Loss of S100A9 (MRP14) results in reduced interleukin-8-induced CD11b surface expression, a polarized microfilament system, and diminished responsiveness to chemoattractants in vitro
MP Manitz et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Diabetes and atherosclerosis - Epidemiology, pathophysiology, and management
JA Beckman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Glucose tolerance and cardiovascular mortality -: Comparison of fasting and 2-hour diagnostic criteria
K Borch-Johnsen et al.
ARCHIVES OF INTERNAL MEDICINE (2001)
Share Paper
